Rory Remmel, PhD
PhD, Medicinal Chemistry, University of Washington
Bachelor of Pharmacy, University of Wyoming
Dr. Remmel is a Distinguished Teaching Professor in the College of Pharmacy.
He is well known as a collaborative investigator in drug metabolism research, with an emphasis on glucuronidation. His research has included studies in basic enzymology, work with hepatocytes, animal studies, and clinical studies in AIDS patients, in patients with epilepsy, and in patients with tuberculosis. He has received multiple teaching awards (including highest teaching award given at the University of Minnesota), especially for teaching antimicrobial agents to pharmacy students.
Awards & Recognition
- Teacher of the Graduating Class of 2012, College of Pharmacy
- Professor of the Year, Pharm. D III Class in 2001, 2003, 2005, 2007 2008, 2009, 2011
- Minnesota Alumni Association Outstanding Contributions to Professional and Graduate Education, 2010
- Outstanding Faculty Award, Council of Graduate Students, 2010
Drug Metabolism and Disposition, Development of Prodrugs of Carbapenems for Tuberculosis, Metabolism, pharmacokinetics, and pharmacogenomics of antiepileptic Agents, Kinetics of UDP-glucuronosyl transferases, Effect of obesity on drug metabolism and disposition.
Meropenem Prodrugs for Treatment of Multi-Drug-Resistant Tuberculosis, Maternal and Childhood Outcomes of Children Borne by Mothers taking antiepileptic agents during pregnancy, Effect of Obesity on Drug Metabolism and Glucuronidation
Epilepsy; Tuberculosis; Effect of Obesity on Drug Metabolism